reSET® 1
by Pear Therapeutics, Inc. 2 variants
reSET 1 is a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID since 15 Jul 2019 (UDI-DI 10851580008071), active as of 23 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10851580008071 | Date15 Jul 2019 | StatusListed |
| United States | FDA De NovoDENG | NumberDEN160018 | Date14 Sep 2017 | StatusActive |
Official records
- AccessGUDID record 10851580008071
- FDA De Novo database DEN160018
From the FDA record
- Device description
- reSET® is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: - increase abstinence from a patient’s substances of abuse during treatment, and - increase retention in the outpatient treatment program.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA De Novo DEN160018 decided 14 Sep 2017 Active
- FDA GUDID UDI-DI 10851580008071 listed 15 Jul 2019 Listed
Timeline
- Granted FDA De Novo DEN160018
- Listed FDA GUDID 10851580008071
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Trade name
- reSET®
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / reference
- 1
- Primary DI / UDI-DI
- 10851580008071
- De Novo Number
- FDA product code
- PWE
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution